快捷搜索:

Zhang Boli: The efficacy of TCM in the fight against COVID-19

指数=1

    Since arriving in Wuhan, 72-year-old academician Zhang Boli has been working around the clock for more than two months investigating the use of traditional Chinese medicine on patients with the novel coronavirus.

Zhang Boli, an academician of the Chinese Academy of Engineering, speaks at a press conference in Wuhan, capital of central China's Hubei province, March 23, 2020. [Photo/Xinhua] 

    Since Zhang Boli arrived in Wuhan as part of the Central Guidance Team on Jan.27, the 72-year-old academician of the Chinese Academy of Engineering (CAE) has been working around the clock for more than two months.

    Zhang, who is also a deputy to the 13th National People's Congress, said he felt duty-bound to help his country at this time of crisis.

    Jiangxia makeshift hospital

    COVID-19 patients in Wuhan, the epicenter of the outbreak in China, have received treatment in collective isolation and under classified management, according to decisions made by the Central Guidance Team. Zhang and other experts in traditional Chinese medicine (TCM) strongly advised the use of TCM on all of the isolated patients.

    With the approval of the Central Guidance Team, Zhang and 208 other experts formed a TCM medical team and started treating patients at a makeshift hospital in Wuhan's Jiangxia district. They decided to apply a comprehensive treatment solution primarily using the Qingfei Paidu Decoction and Xuanfeibaidu Formula, complemented by tai chi, baduanjin and acupuncture therapy.

    Proven efficacy of TCM

    After treatment with the TCM formulas, none of the 564 mild and common patients at the makeshift hospital developed into severe cases. In contrast, WHO statistics show that overall, around 6% to 10% of mild COVID-19 cases develop into severe ones. "More importantly, the blood biochemical indices of the recovered patients, such as the number of lymphocytes and leukocytes, showed significant improvements," explained Zhang.

    The effective practices at Jiangxia Hospital were swiftly applied by other makeshift hospitals, with 90% of such hospitals in Wuhan adopting TCM treatment. Having clearly demonstrated its efficacy, TCM has become an important part of the "Chinese approach to fighting COVID-19."

    Valuing research and treatment

    While promoting the use of TCM, Zhang also stepped-up related scientific research to provide a basis for clinical decisions.

    Zhang is leading a research program to evaluate the clinical value of TCM combined with western medicine in the prevention and treatment of COVID-19, which was launched on Feb. 3. In order to improve the research coverage and allow data to be published in a timely manner, his team developed a dedicated system for the acquisition and analysis of COVID-19 clinical data.

A nurse treats a patient with traditional Chinese medicine (TCM) therapy at a makeshift hospital in Jiangxia district in Wuhan, central China's Hubei province, Feb. 25, 2020. [Photo/Xinhua]

    Meanwhile, TCM experts studied the details of 1,000 patients in varying conditions from nearly 20 hospitals across the country. They concluded that COVID-19 can be considered in TCM terminology as "a disease caused by noxious dampness," giving direction to TCM treatment. Under Zhang's guidance, his team also evaluated the clinical efficacy of various TCM treatments, and carried out drug screening and development.

    Promoting TCM's widespread use

    Many of the medical teams dispatched to Wuhan have now started to head home, but Zhang's return date has yet to be decided.

    After the closure of the Jiangxia makeshift hospital, Zhang shifted the focus of his work to the rehabilitation of recovered patients. "Many severe patients still have such symptoms as heart palpitations and fatigue even after they've been discharged from hospital. Some patients also suffer from damage to their lungs and other organs. We need to assess their conditions and then apply targeted rehabilitation treatments," Zhang said.

    On March 24, a platform offering rehabilitation services for medical workers infected with the virus was put into operation. "The platform is sponsored by the CAE and the Tencent Foundation, with Wuhan Union Hospital and Wuhan Hospital of Traditional Chinese Medicine providing specific services. We're trying to help the medical workers recover completely and return to normal work and life within two to three years," explained Zhang, who is in charge of the platform.

    Meanwhile, the situation in other countries is also worrying to Zhang. "We have empathy for the current situation in Europe and the United States," he said.

    He said that many foreign organizations have invited him to share China's experiences in combating the pandemic, especially regarding the use of TCM.

    "We've given prescriptions to various countries based on their climate and other conditions. In addition, we've also sent them some TCM."

This article was published in Science and Technology Daily in Chinese, and translated by Zhang Liying.

(You can also read it at: http://www.china.org.cn/china/special_coverage/2020-04/06/content_75899205.htm)

张伯礼代表:战疫时候,引发中医药深挚内力

科技日报记者 操秀英 杨朝晖  编辑 龙云

    自信年夜年头?年月三随中央指示组奔赴武汉至今的两个月里,72岁的全国人大年夜代表、中央指示组专家、中国工程院院士张伯礼昼夜奔忙。

“读书人在世,有3件事不能避:为国请命不能避,为国赴难不能避,临危受命不能避。”这是张伯礼赴武汉时的心声,也是他的行动。

    

    江夏方舱的考试测验

    当时,根据疫情中央指示组及时决策,按照专家们的意见推行集中隔离,分类治理。此时,张伯礼等中医专家力主让集中隔离的患者整个吃上中药。

后经中央指示组批准,张伯礼等人组建了一支拥有209位专家的中医医疗队,进驻江夏方舱病院。他们确定了对舱内大年夜多半病人采纳协定的以清肺排毒汤和宣肺败毒方为主的通治方,辅以太极、八段锦和穴位贴敷的综合治疗康复步伐。

    

    数据证实决策有效

    采纳通治方后江夏方舱病院26天运营中收治的新冠肺炎轻症和通俗型患者564人,没有1例从轻症转向重症,而按照天下卫生组织的统计,新冠肺炎轻症患者中约有6%到10%转成重症。“更显明的证据是,出院病人的淋巴细胞数、白细胞数等血液生化指标发生了显着改良。”张伯礼说。

    江夏方舱病院的探索迅速推广到其他方舱病院。中药应用率在汉方舱病院跨越90%。中医药的出色体现成为新冠肺炎治疗“中国规划”的紧张组成部分。

    

    科研与救治两手抓

    在发挥中医药临床救治历程中,张伯礼指示的科研事情也在加速推进,有力支撑临床救治决策。

    实际上,在2月3日启动的“国家科技应急攻关项目——中西医结合防治新型冠状病毒感染的肺炎的临床钻研”,恰是由张伯礼认真。他深入武汉“红区”诊察病情,重要义务便是开展证候学查询造访。为了前进查询造访钻研的覆盖面和数据获取的及时性,并斟酌临床救治实际前提,钻研团队开拓了专门用于新冠肺炎临床数据采集和阐发系统。

    另一方面,对来自全国近20家病院的1000例不合病情分级患者中医证候信息的阐发,中医专家判断这次新冠肺炎是“湿毒疫”,为辨证治疗指清楚明了偏向。张伯礼指示团队也开展中医药临床疗效评价钻研,以及药物筛选与新药研发事情。

    

    光大年夜中医药的脚步不绝 

    今朝,各省支援医疗队已陆续撤离武汉,但张伯礼依然归期不决。

    江夏方舱病院休舱后,张伯礼的事情重心转移到出院病人的康复治疗上。“很多重症患者出院后依然有心悸、乏力等症状,部分病人的肺功能、脏器功能受到侵害,我们首先要进行评估,再对症分环境进行康复。”

    3月24日,张伯礼牵头认真的全国被感染医务职员康复治理平台正式启用。“这是由中国工程院和腾讯基金会支持的平台,由武汉协和病院和武汉市中医病院详细认真,我们争取用两到三年的光阴,让这些医护职员完全康复,回到正常的事情生活轨道。”张伯礼说。

    他也在为国外的疫情焦炙。“看到欧美一些国家的环境,我们感同身受。”张伯礼说,已经有不少国外的单位和组织和他联系,请他先容中国抗疫履历,尤其是中医药的利用,“我们给一些国家根据当地气候特征和环境拟了药方,也寄去了一些中药。”

加载更多>>

您可能还会对下面的文章感兴趣: